Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy.
Zhang Z, Wang Q, Liu Q, Zheng Y, Zheng C, Yi K, Zhao Y, Gu Y, Wang Y, Wang C, Zhao X, Shi L, Kang C, Liu Y.
Zhang Z, et al. Among authors: liu y, liu q.
Adv Mater. 2019 Dec;31(51):e1905751. doi: 10.1002/adma.201905751. Epub 2019 Nov 11.
Adv Mater. 2019.
PMID: 31709671